Atrial Fibrillation Drugs Market to Record Remarkable Growth Rate Over 2021-2025
Category: #healthcare  By Ronak Bora  Date: 2021-03-20
  • share
  • Twitter
  • Facebook
  • LinkedIn

Atrial Fibrillation Drugs Market to Record Remarkable Growth Rate Over 2021-2025

The global atrial fibrillation drugs market is anticipated to record significant growth over the ensuing years on the back of rising geriatric population across the world. Long considered to be one of the most common disorders which leads to an uneven heartbeat, atrial fibrillation has now transitioned into a serious global health concern among the aging population.

Growing inclination towards a sedentary lifestyle supported by proliferating habit of binge eating, specifically among millennials, could give rise to a series of valvular diseases, consequently driving the demand for atrial fibrillation medications.

Request for a sample copy of this report @ https://www.decresearch.com/request-sample/detail/3253

The atrial fibrillation drugs market is essentially gaining traction in the hospital segment in recent years. In fact, the hospital segment was valued at approximately USD 6,583.2 million in the year 2018. The burgeoning popularity of this setting in developed nations owing to easy availability of drug therapies and increasing supply agreements of drugs between manufacturing firms and hospitals are major factors expected to accelerate hospital care for atrial fibrillation over the forecast period. 

Anticoagulant drugs are essentially witnessing increasing demand for the treatment of AF in recent years. Patients with atrial fibrillation are at augmented thromboembolic risk and they are likely to suffer more critical strokes with worse outcomes. However, most thromboembolic complications of this condition are eminently preventable with oral anticoagulation drugs. These drugs have been known for many years to reduce the risk of stroke in AF patients. On this note, studies suggest that the anticoagulant drugs segment is expected to grow at a rate of 3.5% over the forecast period.

Anticoagulant drugs are essentially witnessing increasing demand for the treatment of AF in recent years. Patients with atrial fibrillation are at augmented thromboembolic risk and they are likely to suffer more critical strokes with worse outcomes. However, most thromboembolic complications of this condition are eminently preventable with oral anticoagulation drugs. These drugs have been known for many years to reduce the risk of stroke in AF patients. On this note, studies suggest that the anticoagulant drugs segment is expected to grow at a rate of 3.5% over the forecast period.

Major industry participants such as Sanofi, Bayer AG, Boehringer Ingelheim, Johnson & Johnson, Squibb, Daiichi Sankyo, Pfizer, Bristol-Myers, and AstraZeneca are undertaking several organic and inorganic growth strategies such as mergers, acquisitions, and product launches to tap major market share. These companies are likely to hold the majority market share on account of a strong financial position and better brand recognition.

Request for customization @ https://www.decresearch.com/roc/3253

Partial Chapter of the Table of Content

Chapter 5. Atrial Fibrillation Drugs Market, By Atrial Fibrillation Type

5.1. Global market share, by atrial fibrillation type, 2018 & 2025

5.2. Paroxysmal

5.2.1. Market size, by region, 2014 – 2025 (USD Million)

5.3. Persistent

5.3.1. Market size, by region, 2014 – 2025 (USD Million)

5.4. Permanent

5.4.1. Market size, by region, 2014 – 2025 (USD Million)

Chapter 6. Atrial Fibrillation Drugs Market, By Application

6.1. Global atrial fibrillation drugs market share, by application, 2018 & 2025

6.2. Heart Rhythm Control

6.2.1. Market size, by region, 2014 – 2025 (USD Million)

6.3. Heart Rate Control

6.3.1. Market size, by region, 2014 – 2025 (USD Million)

Chapter 7. Atrial Fibrillation Drugs Market, By Route of Administration

7.1. Global market share, by route of administration, 2018 & 2025

7.2. Oral

7.2.1. Market size, by region, 2014 – 2025 (USD Million)

7.3. Injectable

7.3.1. Market size, by region, 2014 – 2025 (USD Million)

Browse full table of contents (TOC) of this report @ https://www.decresearch.com/toc/detail/atrial-fibrillation-drugs-market

 

About Author

Ronak Bora    

Ronak Bora

A graduate in Electronics Engineering, Ronak writes for Technology Magazine and carries a rich experience in digital marketing, exploring how the online world works from a technical and marketing perspective. His other areas of interest include reading, music, and spo...

Read More>>

More News By Ronak Bora

RF Components Market share 2021 - Industry Growth Analysis to 2027
RF Components Market share 2021 - Industry Growth Analysis to 2027
By Ronak Bora

A detailed analysis of the RF components market is entailed in this research report. The driving for...

Flexible Display Market Size 2021 - Industry Trends Report to 2027
Flexible Display Market Size 2021 - Industry Trends Report to 2027
By Ronak Bora

An inherent blend of vital market definitions, the flexible display market report comprises details ...

Digital BSS Market Size 2021 | Global Industry Statistics Analysis 2027
Digital BSS Market Size 2021 | Global Industry Statistics Analysis 2027
By Ronak Bora

A detailed synopsis of the digital BSS market has been presented in this research report. The synops...